The 20 Best Primitive Neuroectodermal Tumor (PNET) Doctors Near Me in Ypsilanti, MI

Richard Cattaneo is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Cattaneo is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Dr. Leung is the Director of the Neuro-Oncology Fellowship Program and is a clinical assistant professor in the Department of Neurology. She sees patients in the Neuro-Oncology Clinic at the Rogel Cancer Center and at the Northville Health Center. She completed a bachelor’s degree at the University of Western Ontario, a master’s degree at the University of Toronto, and medical degree at SUNY Upstate. Dr. Leung completed her Neurology residency and Neuro-Oncology fellowship at Henry Ford Hospital. Dr. Leung is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Metastatic Brain Tumor.

Dr. Wajd Al-Holou was raised in southeast Michigan. After attending the University of Michigan Medical School, where he graduated with the highest award for research, he then began a 7-year Neurosurgery residency at the University of Michigan. Upon completion of residency in 2016, he completed a Complex Neurosurgical Oncology Fellowship at the MD Anderson Cancer Center in Houston, TX. His training focused on the management of complex brain tumors, spinal tumors, and skull base malignancies.Dr. Al-Holou specializes in the management of complex brain tumors, primarily focusing on gliomas and metastases to the brain. Dr. Al-Holou has expertise in the use of awake mapping techniques, microsurgery, and image-guidance to maximize tumor removal in the safest possible manner. He also specializes in the management of meningiomas and spinal tumors.Dr. Al-Holou is the co-founder and co-director of the Michigan Medicine Multidisciplinary Brain Tumor Clinic (M3BTC). As a member of this Neuro-Oncology multidisciplinary team, he works strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual patient.Currently, he is a member of the AANS/CNS Executive Committee of the Section on Tumors. He served as the Co-Chair for Tumor Section Scientific Program for the American Association of Neurological Surgeons (AANS) in 2018 and is a member of the Society of Neuro-Oncology. He also serves as an editor for cancer journal, BMC Cancer.Dr. Al-Holou is committed to research and education in Neurosurgery and his life-long goal is improving the survival and outcomes for patients with tumors. His research interest focuses primarily on understanding the genetic mechanisms of recurrence in glioblastoma, and in identifying precision medicine therapies to target resistant tumors. Dr. Al is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Astrocytoma, Oligodendroglioma, and Awake Craniotomy.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Jason Heth attended The University of Iowa where he received his medical degree and also completed his residency in Neurosurgery. Dr. Heth then completed additional training in Skull Base Neurosurgery, completing a fellowship at the University of Arkansas for Medical Sciences. After completing his fellowship, he joined the faculty of the University of Michigan. Dr. Heth specializes in brain tumor treatment, including surgical removal, radiosurgery, and basic research. His primary areas of interest focus on gliomas, glioblastoma, brain metastasis, and meningiomas. He is also involved in medical student education and quality improvement programs at the University of Michigan. Dr. Heth is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Gastrostomy.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma.

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Eva Bieniek is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Bieniek is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer.

Samir Narayan is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Narayan is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Posterior Fossa Tumor.

Walter Sahijdak is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Sahijdak is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Philip Stella is an Oncologist in Ypsilanti, Michigan. Dr. Stella is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Pleuropulmonary Blastoma.

Larry Junck is a Neurologist in Ann Arbor, Michigan. Dr. Junck is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

Dr. Mihaylova was born and raised in Bulgaria where she completed Medical School at the University of Sofia in 1997. Subsequently she extended her training into a three-year post-doctoral program and conducted clinical research on newly diagnosed epilepsy patients. She was granted her PhD degree in 2002. Since then she has been living in the US where she completed her Neurology residency at Wayne State University followed by a year of fellowship training in Clinical Neurophysiology with emphasis on Epilepsy/EEG at the same institution. Her primary clinical and research interests involve the treatment of medically intractable epilepsy including VNS and surgical treatment, EEG analysis and seizure semiology. Dr. Mihaylova is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Seizures, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), Generalized Tonic-Clonic Seizure, and Partial Seizure.

Thomas Regenbogen is a Hematologist in Ypsilanti, Michigan. Dr. Regenbogen is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Jerome Winegarden is a Hematologist in Ypsilanti, Michigan. Dr. Winegarden is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Non-Hodgkin Lymphoma, Colorectal Cancer, Familial Colorectal Cancer, and Chronic Lymphocytic Leukemia (CLL).

Carolyn Carrera is a Hematologist in Ypsilanti, Michigan. Dr. Carrera is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Angiosarcoma.

Marie-adele Kress is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Kress has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Breast Cancer, Laryngeal Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

Joel Wilkie is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Wilkie is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are HER-2 Positive Breast Cancer, Lung Cancer, Prostate Cancer, and Familial Prostate Cancer.

Bryan Squires is a Radiation Oncologist in Ypsilanti, Michigan. Dr. Squires is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are HER-2 Positive Breast Cancer, Lung Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Tareq Baghdadi is a Hematologist in Ypsilanti, Michigan. Dr. Baghdadi is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Tissue Biopsy, and Bone Marrow Aspiration.